Gynecomastia: Causes, Evaluation, and When to Seek Treatment
Gynecomastia is benign proliferation of male breast glandular tissue (≥2 cm subareolar). It affects 30–65% of males at some life stage. Distinct from pseudogynecomastia (fat only).
Physiologic Peaks
- Neonatal: Maternal estrogen; resolves in weeks
- Puberty: 50–60% of boys; transient (6–18 months); reassurance usually sufficient
- Aging: >50 years; ↑ body fat (aromatase), ↓ testosterone, medications
Pathologic Causes (If Persistent, Asymmetric, Painful, or Outside Physiologic Windows)
| Category | Examples |
|---|---|
| Hormonal | Testicular tumors (Leydig, Sertoli), adrenal tumors, hyperthyroidism, pituitary adenoma, liver cirrhosis (↓ estrogen clearance), kidney failure |
| Medications (20–25% of cases) | Spironolactone, finasteride, cimetidine, ketoconazole, GnRH analogs, anti-androgens, some antipsychotics, risperidone, calcium channel blockers, isoniazid |
| Substances | Alcohol, marijuana, heroin, anabolic steroids (withdrawal) |
| Genetic | Klinefelter (XXY), aromatase excess, androgen insensitivity |
